文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

2020 年 10 月至 2021 年 3 月意大利流行的 SARS-CoV-2 变异株。

Circulating SARS-CoV-2 variants in Italy, October 2020-March 2021.

机构信息

Department of Biomedical and Clinical Sciences Luigi Sacco, University of Milan, Via G.B. Grassi 74, 20157, Milan, Italy.

Department of Biomedical Sciences and Public Health, Virology Unit, Polytechnic University of Marche, Ancona, Italy.

出版信息

Virol J. 2021 Aug 14;18(1):168. doi: 10.1186/s12985-021-01638-5.

DOI:10.1186/s12985-021-01638-5
PMID:34391446
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8364297/
Abstract

A growing number of emerging SARS-CoV-2 variants is being identified worldwide, potentially impacting the effectiveness of current vaccines. We report the data obtained in several Italian regions involved in the SARS-CoV-2 variant monitoring from the beginning of the epidemic and spanning the period from October 2020 to March 2021.

摘要

越来越多的新型 SARS-CoV-2 变异株正在全球范围内被发现，这可能会影响当前疫苗的有效性。我们报告了自疫情开始以来意大利几个参与 SARS-CoV-2 变异监测的地区的数据，这些数据涵盖了 2020 年 10 月至 2021 年 3 月的时间段。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50ef/8364683/80d2c44f139f/12985_2021_1638_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50ef/8364683/80d2c44f139f/12985_2021_1638_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50ef/8364683/80d2c44f139f/12985_2021_1638_Fig1_HTML.jpg

相似文献

[1]
Circulating SARS-CoV-2 variants in Italy, October 2020-March 2021.

Virol J. 2021-8-14

[2]
A doubt of multiple introduction of SARS-CoV-2 in Italy: A preliminary overview.

J Med Virol. 2020-3-27

[3]
Novel SARS-CoV-2 Variants in Italy: The Role of Veterinary Public Health Institutes.

Viruses. 2021-3-25

[4]
Investigation of an outbreak of symptomatic SARS-CoV-2 VOC 202012/01-lineage B.1.1.7 infection in healthcare workers, Italy.

Clin Microbiol Infect. 2021-8

[5]
Self-collection and pooling of samples as resources-saving strategies for RT-PCR-based SARS-CoV-2 surveillance, the example of travelers in French Polynesia.

PLoS One. 2021

[6]
Genomic epidemiology of SARS-CoV-2 reveals multiple lineages and early spread of SARS-CoV-2 infections in Lombardy, Italy.

Nat Commun. 2021-1-19

[7]
A Founder Effect Led Early SARS-CoV-2 Transmission in Spain.

J Virol. 2021-1-13

[8]
SARS-CoV-2 AY.4.2 variant circulating in Italy: Genomic preliminary insight.

J Med Virol. 2022-4

[9]
A straightforward molecular strategy to retrospectively investigate the spread of SARS-CoV-2 VOC202012/01 B.1.1.7 variant.

J Infect Dev Ctries. 2021-3-7

[10]
SARS-CoV-2 Variants in Rhode Island.

R I Med J (2013). 2021-9-1

引用本文的文献

[1]
Suspected intracranial hypertension in COVID-19 patients with severe respiratory failure.

PLoS One. 2024

[2]
Covid-19 Occupational Risk Incidence and Working Sectors Involved During the Pandemic in Italy.

Saf Health Work. 2023-12

[3]
Extracellular vesicle features are associated with COVID-19 severity.

J Cell Mol Med. 2023-12

[4]
Efficacy and Safety of Reparixin in Patients with Severe COVID-19 Pneumonia: A Phase 3, Randomized, Double-Blind Placebo-Controlled Study.

Infect Dis Ther. 2023-10

[5]
Clinical efficacy of the first two doses of anti-SARS-CoV-2 mRNA vaccines in solid cancer patients.

Cancer Med. 2023-6

[6]
Alterations in the Expression of IFN Lambda, IFN Gamma and Toll-like Receptors in Severe COVID-19 Patients.

Microorganisms. 2023-3-8

[7]
Host Response of Syrian Hamster to SARS-CoV-2 Infection including Differences with Humans and between Sexes.

Viruses. 2023-2-3

[8]
Remdesivir Influence on SARS-CoV-2 RNA Viral Load Kinetics in Nasopharyngeal Swab Specimens of COVID-19 Hospitalized Patients: A Real-Life Experience.

Microorganisms. 2023-1-25

[9]
Negative predictive value of the FebriDx host response point-of-care test in patients presenting to a single Australian emergency department with suspected COVID-19: an observational diagnostic accuracy study.

BMJ Open. 2022-12-29

[10]
Epidemiological and Clinical Features of SARS-CoV-2 Variants Circulating between April-December 2021 in Italy.

Viruses. 2022-11-12

本文引用的文献

[1]
Emergence and Spread of SARS-CoV-2 Lineages B.1.1.7 and P.1 in Italy.

Viruses. 2021-4-29

[2]
Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021.

Euro Surveill. 2021-4

[3]
Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil.

Science. 2021-5-21

[4]
The first familial cluster of the B.1.1.7 variant of SARS-CoV-2 in the northeast of Italy.

Infection. 2021-12

[5]
Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England.

Nature. 2021-5

[6]
Case fatality risk of the SARS-CoV-2 variant of concern B.1.1.7 in England, 16 November to 5 February.

Euro Surveill. 2021-3

[7]
Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7.

Nature. 2021-5

[8]
Detection of a SARS-CoV-2 variant of concern in South Africa.

Nature. 2021-4

[9]
Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study.

BMJ. 2021-3-9

[10]
Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England.

Science. 2021-4-9

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索